oa CSIR Science Scope - Picking up where pharmaceutical giants have left off : developing an artemisinin alternative : malaria
In another research project, Dr Chris Parkinson and his team of synthetic chemists are pursuing a similar objective : a new malaria drug; fewer side effects; affordable; with reduced reliance on a single source. They have set their minds on developing an artemisinin-based derivative. This class of drugs, called peroxides, is the only class of drugs to which Plasmodium falciparum has not yet shown signs of resistance. Recent Cambodian studies, however, have shown a slowing down in the rate at which the artemisinins act - suggesting that true resistance may emerge in the near future.
Article metrics loading...